KIMS774.00

Krishna Institute of Medical Sciences Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersAPOLLOHOSPMAXHEALTHFORTISJUBLPHARMAINDGNONESOURCEPFIZERPOLYMEDMcap ₹30,960 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations2,498.13,035.13,904.64,212.5
Other Income13.131.926.235.5
Total Income2,511.23,067.03,930.84,248.0
Expenses
+ Purchases of Stock-in-Trade536.9640.4841.8911.0
+ Changes in Inventories-6.6-13.5-32.9-41.4
+ Employee Benefit Expense422.4499.5681.7743.3
+ Finance Costs47.090.3202.5253.3
+ Depreciation & Amortisation146.5177.2283.2330.6
+ Other Expenses905.11,125.81,612.01,766.8
Total Expenses2,051.32,519.73,588.33,963.6
EBITDA640.4782.9802.0832.8
EBIT493.9605.7518.8502.2
Profit
PBT before Exceptional Items459.9547.3342.5284.4
+ Exceptional Items0.010.8-11.2-11.2
Pretax Income459.9558.1331.3273.2
+ Current Tax119.6149.5136.2139.4
+ Deferred Tax4.0-6.2-44.3-57.0
Tax Expense123.6143.391.982.4
+ Share of Associates & JVs-0.30.02.63.6
Net Income336.0414.8242.0194.4
+ Net Income — Continuing Ops336.3414.8239.4190.8
+ Other Comprehensive Income0.3-2.30.20.7
Total Comprehensive Income336.3412.5242.2195.1
Net Income to Common310.1384.5241.4204.5
Minority Interest25.930.30.6-9.8
Per Share
Basic EPS38.759.616.035.10
Diluted EPS38.759.616.035.10
Other Comprehensive Income — detail
+ Other Comprehensive Income-2.30.20.7
+ Tax on Items NOT to be Reclassified3.1-0.2-0.8
+ Tax on Items NOT to be Reclassified — alt tag-0.4
+ Tax on Items to be Reclassified-0.80.00.1
+ Tax on Items to be Reclassified — alt tag0.1
Comprehensive Income — Owners of Parent310.4382.5241.543.0
Comprehensive Income — Non-controlling Interests25.930.00.7-9.2
Per Share — as-filed variants
Basic EPS — Continuing Operations38.759.616.035.10
Diluted EPS — Continuing Operations38.759.616.035.10
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit1,967.92,408.23,095.73,342.9
Gross Margin %78.7779.3479.2879.36
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)459.9547.3342.5284.4
− Exceptional Items (reconciliation)0.010.8-11.2-11.2
Net Income Adj (tax-effected)336.0406.8250.1202.2
EPS Adj38.759.426.235.31
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.002.002.002.00
Paid Up Equity Capital80.080.080.084.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.